MedDataX Logo

Mast Cells and Its Proteases in COPD

NCT ID: NCT06392334

Last Updated: 2024-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-29

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mast cells proteases such as chymase and tryptase will be studied in the tissue of small and large airways in COPD patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Exacerbation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

mast cell tryptase chymase COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Biopsy

Biopsy of lung tissue will be done

Group Type OTHER

Biopsy

Intervention Type OTHER

Biopsy of lung tissue

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biopsy

Biopsy of lung tissue

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- COPD patients

Exclusion Criteria

Other lung diseases, tumors, pregnancy

\-
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Voronezh N.N. Burdenko State Medical Academy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Voronezh State Medical University

Voronezh, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yanina Shkatova

Role: CONTACT

Phone: 89611875800

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yanina Shkatova

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Voronezhsma

Identifier Type: -

Identifier Source: org_study_id